Concepedia

Kevin Kalinsky

KK

Statistics

Publications

82

Citations

7.8K

H-Index

40

Active since

2009

Affiliations

Columbia University Irving Medical Center(Current)

Emory University

Massachusetts General Hospital

Dana-Farber Cancer Institute

University of California, San Francisco

Kevin Kalinsky is an author at Columbia University Irving Medical Center specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2009–2025

82

Publications

82

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

, , +17

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat et al. · New England Journal of Medicine · 2019 · 850 citations

, , +17

PIK3CA Mutation Associates with Improved Outcome in Breast Cancer

Kevin Kalinsky, Lindsay M. Jacks, Adriana Heguy et al. · Clinical Cancer Research · 2009 · 416 citations

, , +12

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond et al. · Journal of Clinical Oncology · 2017 · 409 citations

, , +12

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Aditya Bardia, Wells A. Messersmith, Ebenezer A. Kio et al. · Annals of Oncology · 2021 · 375 citations

, , +17

1–5 of 82